However, CD44 expression apparently decreased within bladder urothelial carcinoma (BLCA), lung adenocarcinoma (LUAD), prostate adenocarcinoma (PRAD), and uterine corpus endometrial carcinoma (UCEC) tissues (Figure 1C). Here, CD44 is linked to uterine corpus endometrial carcinoma.